A student at the Yale School of Public Health is working in collaboration with the U.S. government to support COVID-19 screening programs nationwide.
December 10, 2021
A recent study conducted by researchers at the Yale School of Medicine reveals that high-income countries have received greater access to COVID-19 vaccines than low- and middle-income countries, likely due to failures in vaccine delivery and a tendency of private vaccine manufacturers to prioritize nations that can pay a higher premium for doses.
December 7, 2021
A new Yale study is investigating the use and effectiveness of a potential nasal vaccine technology that could help put an end to the pandemic.
The first case of the Omicron variant has been reported in the state of Connecticut. Health care experts believe there are more cases in Connecticut which have not yet been detected.
December 6, 2021
A new Yale co-led report in The Lancet examines the current state of COVID-19 vaccine refusal and acceptance, as well as strategies for addressing vaccine hesitancy in the United States.
December 2, 2021
Researchers at the Yale School of Public Health and the School of Medicine identified a SARS-CoV-2 remdesivir resistance mutation in an immunocompromised patient.
In recent weeks, COVID-19 cases have steadily risen within Yale University and the greater New Haven area.
December 1, 2021
Yale New Haven Hospital revealed that 90 percent of hospitalized COVID-19 patients did not receive the COVID-19 vaccine.
COVID-19 has exacerbated existing inequities in global health, with an especially high toll on developing countries.
November 12, 2021
According to a Yale study, it is more effective to tell people that vaccines protect others than that vaccines protect their own health.
November 10, 2021
SalivaDirect, a COVID-19 test developed at the Yale School of Public Health, receives FDA approval for pooled testing.
November 9, 2021